NEW YORK, April 4, 2024 /PRNewswire/ Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the.
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Delcath Systems (NASDAQ:DCTH – Free Report) had its price objective boosted by HC Wainwright from $18.00 to $20.00 in a report published on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Delcath Systems’ Q1 2025 earnings at ($0.25) EPS, Q2 2025 earnings at ($0.26) […]
Delcath Systems (NASDAQ:DCTH) Announces Earnings Results kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Delcath Systems (NASDAQ:DCTH – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.48) EPS for the quarter, beating the consensus estimate of ($0.67) by $0.19, RTT News reports. The company had revenue of $0.54 million for the quarter, compared to analyst estimates of $0.48 million. Delcath Systems had a negative […]